View drug registration information details.
| Items | Registration information |
|---|
| ID | 428 |
|---|
| No | 428 |
|---|
| Brand Name | AVASTIN 400 MG/16 ML |
|---|
| Ingredients | BEVACIZUMAB 400 MG/16 ml |
|---|
| Dosage Form | SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL X 16 ML |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | METASTATIC COLORECTAL CANCER, LOCALLY RECURRENT OR METASTATIC BREAST CANCER; ADVANCED, METASTATIC OR RECURRENT NON SMALL CELL LUNG CANCER; ADVANCED AND /OR METASTATIC RENAL CELL CANCER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | COLORLESS, OPALESCENT LIQUID |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | F.HOFFMANN LA ROCHE LTD. |
|---|
| Country | SWITZERLAND |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 06 I 3124/08 |
|---|
| FDD Registration Date | 22-JUL-2022 |
|---|
| Expiry Date | 21-JUL-2025 |
|---|
Back to drug list
|
